世界の選択的セロトニン再取り込み阻害薬（SSRI）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6005 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シタロプラム（セレクサ）、エスシタロプラム（レクサプロ）、フルオキセチン（プロザック）、パロキセチン（パキシル、ペクセバ）、セルトラリン（ゾロフト）、ビラゾドン（ビラゾドン））、用途別市場規模（うつ病、不安神経症、パニック障害、その他精神状態）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・選択的セロトニン再取り込み阻害薬（SSRI）の市場動向 ・企業の競争状況、市場シェア ・選択的セロトニン再取り込み阻害薬（SSRI）の種類別市場規模と予測2016-2027（シタロプラム（セレクサ）、エスシタロプラム（レクサプロ）、フルオキセチン（プロザック）、パロキセチン（パキシル、ペクセバ）、セルトラリン（ゾロフト）、ビラゾドン（ビラゾドン）） ・選択的セロトニン再取り込み阻害薬（SSRI）の用途別市場規模と予測2016-2027（うつ病、不安神経症、パニック障害、その他精神状態） ・選択的セロトニン再取り込み阻害薬（SSRI）の北米市場規模2016-2027（アメリカ、カナダ） ・選択的セロトニン再取り込み阻害薬（SSRI）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・選択的セロトニン再取り込み阻害薬（SSRI）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・選択的セロトニン再取り込み阻害薬（SSRI）の中南米市場規模2016-2027（メキシコ、ブラジル） ・選択的セロトニン再取り込み阻害薬（SSRI）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan Plc、Eli Lilly and Co.、GlaxoSmithKline Plc、H. Lundbeck AS、Pfizer Inc.） ・結論

Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They can ease symptoms of moderate to severe depression, are relatively safe and typically cause fewer side effects than other types of antidepressants do.
With an increase in mental illnesses, there is a rising need for effective neurological drugs. Among the various neurological drugs available in the market, SSRIs drugs have high therapeutic efficacy. As a result, the number of vendors manufacturing these drugs is increasing. Moreover, health insurance companies, with support from governments, have started covering treatment expenses related to mental disorder. The rising prevalence of mental illnesses will significantly contribute to the selective serotonin reuptake inhibitors market growth.

Market Analysis and Insights: Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market
The global Selective Serotonin Reuptake Inhibitors (SSRIs) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Selective Serotonin Reuptake Inhibitors (SSRIs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Selective Serotonin Reuptake Inhibitors (SSRIs) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Selective Serotonin Reuptake Inhibitors (SSRIs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Selective Serotonin Reuptake Inhibitors (SSRIs) market.

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Scope and Market Size
Selective Serotonin Reuptake Inhibitors (SSRIs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Selective Serotonin Reuptake Inhibitors (SSRIs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Citalopram (Celexa)
Escitalopram (Lexapro)
Fluoxetine (Prozac)
Paroxetine (Paxil, Pexeva)
Sertraline (Zoloft)
Vilazodone (Viibryd)

Segment by Application
Depression
Anxiety and panic disorder
Other mental conditions

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan Plc
Eli Lilly and Co.
GlaxoSmithKline Plc
H. Lundbeck AS
Pfizer Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Citalopram (Celexa)
1.2.3 Escitalopram (Lexapro)
1.2.4 Fluoxetine (Prozac)
1.2.5 Paroxetine (Paxil, Pexeva)
1.2.6 Sertraline (Zoloft)
1.2.7 Vilazodone (Viibryd)
1.3 Market by Application
1.3.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Depression
1.3.3 Anxiety and panic disorder
1.3.4 Other mental conditions
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Perspective (2016-2027)
2.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Growth Trends by Regions
2.2.1 Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Historic Market Share by Regions (2016-2021)
2.2.3 Selective Serotonin Reuptake Inhibitors (SSRIs) Forecasted Market Size by Regions (2022-2027)
2.3 Selective Serotonin Reuptake Inhibitors (SSRIs) Industry Dynamic
2.3.1 Selective Serotonin Reuptake Inhibitors (SSRIs) Market Trends
2.3.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Market Drivers
2.3.3 Selective Serotonin Reuptake Inhibitors (SSRIs) Market Challenges
2.3.4 Selective Serotonin Reuptake Inhibitors (SSRIs) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Selective Serotonin Reuptake Inhibitors (SSRIs) Players by Revenue
3.1.1 Global Top Selective Serotonin Reuptake Inhibitors (SSRIs) Players by Revenue (2016-2021)
3.1.2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Players (2016-2021)
3.2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue
3.4 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Concentration Ratio
3.4.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue in 2020
3.5 Selective Serotonin Reuptake Inhibitors (SSRIs) Key Players Head office and Area Served
3.6 Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Product Solution and Service
3.7 Date of Enter into Selective Serotonin Reuptake Inhibitors (SSRIs) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Selective Serotonin Reuptake Inhibitors (SSRIs) Breakdown Data by Type
4.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Historic Market Size by Type (2016-2021)
4.2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Forecasted Market Size by Type (2022-2027)

5 Selective Serotonin Reuptake Inhibitors (SSRIs) Breakdown Data by Application
5.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Historic Market Size by Application (2016-2021)
5.2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2016-2027)
6.2 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
6.2.1 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2021)
6.2.2 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2022-2027)
6.2.3 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2027)
6.3 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application
6.3.1 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2021)
6.3.2 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2022-2027)
6.3.3 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2027)
6.4 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country
6.4.1 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2016-2021)
6.4.2 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2016-2027)
7.2 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
7.2.1 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2021)
7.2.2 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2022-2027)
7.2.3 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2027)
7.3 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application
7.3.1 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2021)
7.3.2 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2022-2027)
7.3.3 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2027)
7.4 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country
7.4.1 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2016-2021)
7.4.2 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2016-2027)
8.2 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
8.2.1 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2027)
8.3 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application
8.3.1 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2027)
8.4 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region
8.4.1 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2016-2027)
9.2 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
9.2.1 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2021)
9.2.2 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2022-2027)
9.2.3 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2027)
9.3 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application
9.3.1 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2021)
9.3.2 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2022-2027)
9.3.3 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2027)
9.4 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country
9.4.1 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2016-2021)
9.4.2 Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2016-2027)
10.2 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
10.2.1 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2027)
10.3 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application
10.3.1 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2027)
10.4 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country
10.4.1 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Company Details
11.1.2 Allergan Plc Business Overview
11.1.3 Allergan Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Introduction
11.1.4 Allergan Plc Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021)
11.1.5 Allergan Plc Recent Development
11.2 Eli Lilly and Co.
11.2.1 Eli Lilly and Co. Company Details
11.2.2 Eli Lilly and Co. Business Overview
11.2.3 Eli Lilly and Co. Selective Serotonin Reuptake Inhibitors (SSRIs) Introduction
11.2.4 Eli Lilly and Co. Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021)
11.2.5 Eli Lilly and Co. Recent Development
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Details
11.3.2 GlaxoSmithKline Plc Business Overview
11.3.3 GlaxoSmithKline Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Introduction
11.3.4 GlaxoSmithKline Plc Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021)
11.3.5 GlaxoSmithKline Plc Recent Development
11.4 H. Lundbeck AS
11.4.1 H. Lundbeck AS Company Details
11.4.2 H. Lundbeck AS Business Overview
11.4.3 H. Lundbeck AS Selective Serotonin Reuptake Inhibitors (SSRIs) Introduction
11.4.4 H. Lundbeck AS Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021)
11.4.5 H. Lundbeck AS Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Selective Serotonin Reuptake Inhibitors (SSRIs) Introduction
11.5.4 Pfizer Inc. Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021)
11.5.5 Pfizer Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Citalopram (Celexa)
Table 3. Key Players of Escitalopram (Lexapro)
Table 4. Key Players of Fluoxetine (Prozac)
Table 5. Key Players of Paroxetine (Paxil, Pexeva)
Table 6. Key Players of Sertraline (Zoloft)
Table 7. Key Players of Vilazodone (Viibryd)
Table 8. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Regions (2016-2021)
Table 12. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Regions (2022-2027)
Table 14. Selective Serotonin Reuptake Inhibitors (SSRIs) Market Trends
Table 15. Selective Serotonin Reuptake Inhibitors (SSRIs) Market Drivers
Table 16. Selective Serotonin Reuptake Inhibitors (SSRIs) Market Challenges
Table 17. Selective Serotonin Reuptake Inhibitors (SSRIs) Market Restraints
Table 18. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Players (2016-2021)
Table 20. Global Top Selective Serotonin Reuptake Inhibitors (SSRIs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) as of 2020)
Table 21. Ranking of Global Top Selective Serotonin Reuptake Inhibitors (SSRIs) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Product Solution and Service
Table 25. Date of Enter into Selective Serotonin Reuptake Inhibitors (SSRIs) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Type (2016-2021)
Table 29. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Application (2016-2021)
Table 33. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2022-2027) & (US$ Million)
Table 65. Allergan Plc Company Details
Table 66. Allergan Plc Business Overview
Table 67. Allergan Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Product
Table 68. Allergan Plc Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021) & (US$ Million)
Table 69. Allergan Plc Recent Development
Table 70. Eli Lilly and Co. Company Details
Table 71. Eli Lilly and Co. Business Overview
Table 72. Eli Lilly and Co. Selective Serotonin Reuptake Inhibitors (SSRIs) Product
Table 73. Eli Lilly and Co. Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021) & (US$ Million)
Table 74. Eli Lilly and Co. Recent Development
Table 75. GlaxoSmithKline Plc Company Details
Table 76. GlaxoSmithKline Plc Business Overview
Table 77. GlaxoSmithKline Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Product
Table 78. GlaxoSmithKline Plc Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021) & (US$ Million)
Table 79. GlaxoSmithKline Plc Recent Development
Table 80. H. Lundbeck AS Company Details
Table 81. H. Lundbeck AS Business Overview
Table 82. H. Lundbeck AS Selective Serotonin Reuptake Inhibitors (SSRIs) Product
Table 83. H. Lundbeck AS Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021) & (US$ Million)
Table 84. H. Lundbeck AS Recent Development
Table 85. Pfizer Inc. Company Details
Table 86. Pfizer Inc. Business Overview
Table 87. Pfizer Inc. Selective Serotonin Reuptake Inhibitors (SSRIs) Product
Table 88. Pfizer Inc. Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021) & (US$ Million)
Table 89. Pfizer Inc. Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type: 2020 VS 2027
Figure 2. Citalopram (Celexa) Features
Figure 3. Escitalopram (Lexapro) Features
Figure 4. Fluoxetine (Prozac) Features
Figure 5. Paroxetine (Paxil, Pexeva) Features
Figure 6. Sertraline (Zoloft) Features
Figure 7. Vilazodone (Viibryd) Features
Figure 8. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application: 2020 VS 2027
Figure 9. Depression Case Studies
Figure 10. Anxiety and panic disorder Case Studies
Figure 11. Other mental conditions Case Studies
Figure 12. Selective Serotonin Reuptake Inhibitors (SSRIs) Report Years Considered
Figure 13. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Regions: 2020 VS 2027
Figure 16. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Regions (2022-2027)
Figure 17. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Players in 2020
Figure 18. Global Top Selective Serotonin Reuptake Inhibitors (SSRIs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue in 2020
Figure 20. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Type (2016-2021)
Figure 21. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Type (2022-2027)
Figure 22. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2016-2027)
Figure 24. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2016-2027)
Figure 25. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2016-2027)
Figure 26. United States Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2016-2027)
Figure 30. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2016-2027)
Figure 31. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2016-2027)
Figure 32. Germany Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Region (2016-2027)
Figure 42. China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2016-2027)
Figure 50. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2016-2027)
Figure 51. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2016-2027)
Figure 52. Mexico Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2016-2027)
Figure 58. Turkey Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Allergan Plc Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021)
Figure 62. Eli Lilly and Co. Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021)
Figure 63. GlaxoSmithKline Plc Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021)
Figure 64. H. Lundbeck AS Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021)
Figure 65. Pfizer Inc. Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---